Clearmind Biomedical has signed an exclusive US distribution agreement with Sutter Medical for the Neuroblade Multi-Function Neuro-Endoscope System, a 510(k)-cleared device engineered to advance the treatment of complex neurosurgical conditions such as intracerebral hemorrhage (ICH).

ICH remains one of the most devastating forms of stroke, with limited treatment options, high mortality, and severe disability rates. The Neuroblade system addresses this unmet need by providing neurosurgeons with a new paradigm for hemorrhage evacuation: a single, minimally invasive platform that integrates visualisation, illumination, irrigation, suction, coagulation, and powered debridement. This combination is designed to streamline surgical workflow, reduce instrument exchanges, and improve surgical precision–ultimately enhancing patient outcomes and the potential for recovery.

J Dustin Duckett, Vice President and General Manager, Clearmind, Americas, said, "Clearmind's mission has always been to simplify and advance the surgical treatment of hemorrhagic stroke, so patients not only survive but return to independent lives. By partnering with Sutter Medical, we can accelerate adoption of the Neuroblade across leading stroke and neurosurgical centres in the US, giving surgeons the tools they need to treat ICH more effectively."

Under the agreement, Sutter Medical—globally recognised for its non-stick bipolar forceps and radiofrequency systems—will serve as the exclusive distributor of the Neuroblade in the United States. With its established commercial infrastructure and trusted surgeon relationships, Sutter will expand access to this next-generation technology.

"We are proud to add the Neuroblade to our US portfolio. It's unique combination of minimally invasive access and integrated functionality aligns perfectly with our mission to provide neurosurgeons with tools that improve surgical workflow, precision and enhance patient outcomes,” said Brent Lacy, Vice President, Sutter.

The Neuroblade will be featured at the Congress of Neurological Surgeons (CNS) Annual Meeting, October 11-15th, 2025 at Booth #350.